Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

134.31
Delayed Data
As of Jun 23
 +0.63 / +0.47%
Today’s Change
94.42
Today|||52-Week Range
135.18
+16.03%
Year-to-Date
On Not Talking About the 'Market'; Darth Vader, Meet Amazon: Jim Cramer's Best Blog
Jun 23 / TheStreet.com - Paid Partner Content
Celgene Heading for All-Time High
Jun 21 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonob...
Jun 23 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Biotech Stocks Finally Stage Breakthrough
Jun 22 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
Celgene Presents Interim Results from Cancer Drug Study
Jun 19 / Zacks.com - Paid Partner Content
Cramer: This Is No Country for Old Value
Jun 21 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Procter & Gamble, Celgene, PayPal and South...
Jun 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close133.68
Today’s open133.50
Day’s range131.72 - 134.56
Volume4,757,377
Average volume (3 months)3,909,560
Market cap$104.9B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+22.68%
Earnings growth (next 5 years)+20.02%
Revenue growth (last year)+22.70%
P/E ratio50.5
Price/Sales8.51
Price/Book15.85

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.13+0.29%
ABBVAbbVie-0.54-0.74%
BMYBristol-Myers Squibb-0.69-1.20%
LLYEli Lilly and Co-0.42-0.50%
Data as of 4:03pm ET, 06/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts